Unews World
For the first time, people at high risk of lung cancer can participate in a clinical trial of an experimental vaccine designed to prevent the disease. Led by University College London and the University of Oxford, this groundbreaking trial marks a major step in cancer prevention. Unlike conventional treatments, which target cancer after it develops, the vaccine aims to train …
Read More »World’s first lung cancer prevention vaccine trial funded with £2.06 million to stop cancer before it starts | – The Times of India
